214 related articles for article (PubMed ID: 22350586)
1. Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.
Olsen H; Nordenström E; Bergenfelz A; Nyman U; Valdemarsson S; Palmqvist E
Endocrine; 2012 Aug; 42(1):164-73. PubMed ID: 22350586
[TBL] [Abstract][Full Text] [Related]
2. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
[TBL] [Abstract][Full Text] [Related]
3. The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion.
Kim BJ; Kwak MK; Ahn SH; Kim JS; Lee SH; Koh JM
Osteoporos Int; 2018 Oct; 29(10):2299-2307. PubMed ID: 29971455
[TBL] [Abstract][Full Text] [Related]
4. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
Ahn SH; Kim JH; Cho YY; Suh S; Kim BJ; Hong S; Lee SH; Koh JM; Song KH
Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548
[TBL] [Abstract][Full Text] [Related]
5. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma.
Masserini B; Morelli V; Bergamaschi S; Ermetici F; Eller-Vainicher C; Barbieri AM; Maffini MA; Scillitani A; Ambrosi B; Beck-Peccoz P; Chiodini I
Eur J Endocrinol; 2009 Jan; 160(1):87-92. PubMed ID: 18835977
[TBL] [Abstract][Full Text] [Related]
6. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
7. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
8. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
[TBL] [Abstract][Full Text] [Related]
9. Influence of adrenal subclinical hypercortisolism on hypertension in patients with adrenal incidentaloma.
Oki K; Yamane K; Nakanishi S; Shiwa T; Kohno N
Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):244-7. PubMed ID: 22328110
[TBL] [Abstract][Full Text] [Related]
10. Mental Health in Patients With Adrenal Incidentalomas: Is There a Relation With Different Degrees of Cortisol Secretion?
Morelli V; Ghielmetti A; Caldiroli A; Grassi S; Siri FM; Caletti E; Mucci F; Aresta C; Passeri E; Pugliese F; Di Giorgio A; Corbetta S; Scillitani A; Arosio M; Buoli M; Chiodini I
J Clin Endocrinol Metab; 2021 Jan; 106(1):e130-e139. PubMed ID: 33017843
[TBL] [Abstract][Full Text] [Related]
11. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
12. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
[TBL] [Abstract][Full Text] [Related]
13. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
[TBL] [Abstract][Full Text] [Related]
14. The Role of Cortisol/ACTH Ratio for Screening of Subclinical Hypercortisolism in Patients with Adrenal Incidentalomas.
Li L; Yang G; Dou J; Gu W; Lv Z; Lu J; Mu Y
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):71-76. PubMed ID: 28931176
[TBL] [Abstract][Full Text] [Related]
15. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
[TBL] [Abstract][Full Text] [Related]
16. Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH.
Olsen H; Olofsson L; Mjöman M
Clin Endocrinol (Oxf); 2014 Mar; 80(3):335-41. PubMed ID: 23865937
[TBL] [Abstract][Full Text] [Related]
17. Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism.
Salcuni AS; Morelli V; Eller Vainicher C; Palmieri S; Cairoli E; Spada A; Scillitani A; Chiodini I
Eur J Endocrinol; 2016 Mar; 174(3):261-9. PubMed ID: 26630908
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Size and Function of Unilateral and Bilateral Adrenocortical Nodules: An Observational Study.
Huayllas MKP; Sirineni GK; Smith LM; Gallagher JC; Singh RJ; Netzel BC; Kater CE
AJR Am J Roentgenol; 2020 Apr; 214(4):800-807. PubMed ID: 32069079
[No Abstract] [Full Text] [Related]
19. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.
Ceccato F; Barbot M; Albiger N; Antonelli G; Zilio M; Todeschini M; Regazzo D; Plebani M; Lacognata C; Iacobone M; Mantero F; Boscaro M; Scaroni C
Endocrine; 2018 Mar; 59(3):510-519. PubMed ID: 28956262
[TBL] [Abstract][Full Text] [Related]
20. Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
Sane T; Schalin-Jäntti C; Raade M
J Clin Endocrinol Metab; 2012 Jun; 97(6):2077-83. PubMed ID: 22492870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
